生物钟和代谢性瘤发生的相互作用
Zheng Wang1, Leina Ma2, Ying Meng1
1Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310029, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang 310029, China.
Trends in cell biology
|December 7, 2023
概括
癌细胞破坏昼夜时钟和新陈代谢,改变关键过程,如糖解和脂质合成. 瘤基因重新编程了时钟基因,推动了瘤的生长和扩散.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢研究 研究 代谢研究
背景情况:
- 昼夜时钟调节生理过程,而细胞代谢提供能量和构建块.
- 昼夜节律和新陈代谢在癌症中经常发生变化.
- 瘤微环境影响这些细胞过程.
研究的目的:
- 阐明昼夜时钟与癌细胞代谢之间的复杂相互作用.
- 了解这种相互作用如何影响对瘤生长至关重要的代谢途径.
主要方法:
- 审查关于昼夜钟基因,癌症代谢和瘤信号的现有文献.
- 分析核心时钟基因如何在癌症中被选择.
- 检查癌细胞中代谢途径失调的情况.
主要成果:
- 在癌症中,循环时钟和细胞代谢通过内在和外在因素受到调节.
- 相互作用控制关键的代谢过程:有氧糖解,核酸合成,氨基酸和脂质代谢,线粒体功能和氧化还原平衡.
- 瘤信号劫持了时钟基因,重编程了新陈代谢以支持癌症的扩散.
结论:
- 昼夜钟与癌症代谢之间的复杂关系是癌症的标志.
- 了解这些相互交织的机制对于开发新型癌症疗法至关重要.
相关概念视频
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


